Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Becton Dickinson (NY:BDX)

199.09 -3.65 (-1.80%)
Streaming Delayed Price Updated: 1:30 PM EST, Jan 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Becton Dickinson

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
News headline image
Insulin Device Maker Embecta Weighs Sale After 70% Share Decline Following Becton Dickinson Spin-Off ↗
Embecta is exploring a potential sale after a nearly 70% drop in share price since its spin-off from Becton Dickinson. The company's U.S. business has struggled with the rise of GLP-1 drugs and... 
Via Benzinga
News headline image
Looking Into Becton Dickinson's Recent Short Interest ↗
 
Via Benzinga
News headline image
3 Healthcare Stocks to Buy Now to Profit From Aging Population Trends ↗
With the baby boom turning into a retirement bonanza, investors should consider these senior-focused healthcare stocks. 
Via InvestorPlace
Topics Retirement
News headline image
UnitedHealth, Edwards Lifesciences, First Citizens Bank And More: CNBC's 'Final Trades' ↗
UnitedHealth Group was declared a "solid" healthcare company on CNBC. Cantor Fitzgerald analyst Sarah James maintains a price target of $591. 
Via Benzinga
News headline image
Boing! 7 Undervalued Stocks That Could Surprise the Skeptics. ↗
The market previously supported a higher multiple for these undervalued stocks, making them attractive contrarian targets. 
Via InvestorPlace
News headline image
Peering Into Becton Dickinson's Recent Short Interest ↗
 
Via Benzinga
News headline image
Looking Into Becton Dickinson's Recent Short Interest ↗
 
Via Benzinga
News headline image
Peering Into Becton Dickinson's Recent Short Interest ↗
 
Via Benzinga
News headline image
Stock Market Revs To Highs On Nvidia, CrowdStrike, Yields: Weekly Review ↗
The Nasdaq and S&P 500 hit record highs, but small caps retreated. 
Via Investor's Business Daily
Topics Stocks
News headline image
BD Bolsters Portfolio With $4.2B Cash Deal For Edwards Lifesciences' Critical Care Group: Details ↗
BD (Becton, Dickinson and Company) will acquire Edwards Lifesciences' Critical Care product group for $4.2 billion in cash. This acquisition enhances BD's portfolio with advanced AI-enabled monitoring... 
Via Benzinga
News headline image
Edwards Lifesciences Stock Nears Breakout On A Surprise $4.2 Billion Deal ↗
Edwards Lifesciences stock rallied Monday on medtech giant Becton Dickinson's plan to buy a key division for $4.2 billion. 
Via Investor's Business Daily
News headline image
Trade Winds Turning: 3 Stocks Poised to Gain from Biden’s China Tariffs ↗
Here are three potential stocks to buy that could benefit from China tariffs amidst the turning trade winds. 
Via InvestorPlace
Topics World Trade
News headline image
Biden's New Tariffs On Chinese Imports Are A 'Clear Giveaway' To These Two Tesla Rivals, Jim Cramer Says: 'I Like This Policy' ↗
Jim Cramer has highlighted the potential benefits for U.S. automakers, particularly Ford and General Motors, following the Biden administration's decision to impose substantial tariffs on Chinese... 
Via Benzinga
Topics World Trade
News headline image
MarketBeat Week in Review – 4/29 - 5/3
Apple, Amgen, and a weak jobs report helped move the market higher as investors temporarily looked past the possibility of no interest rate cuts in 2024 
Via MarketBeat
Topics Economy Stocks
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Becton & Dickinson 'Is Well On Its Way To Achieving 2025 Commitments,' Analyst Optimistic On Outlook ↗
BD reports Q2 sales of $5.04 billion, up 4.6% Y/Y. BD Medical, Life Sciences, and Interventional segments show growth. Guidance was raised for 2024 sales, and EPS was adjusted. William Blair rates BDX... 
Via Benzinga
News headline image
BDX Stock Earnings: Becton, Dickinson Beats EPS, Beats Revenue for Q2 2024 ↗
BDX stock results show that Becton, Dickinson beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Medical device maker Boston Scientific Co. defies Medtech slowdown and delivers a solid Q1 2024 earnings report, and raises 2024 outlook. 
Via MarketBeat
News headline image
How Much Will $10k Invested in These Dividend Aristocrats Grow to by 2025? ↗
Curious to know how much these dividend aristocrats could grow in the next year? Here's the answer for several well-known shares. 
Via InvestorPlace
News headline image
Rich Returns at a Discount: 3 Dividend Aristocrats Trading at 52-Week Lows ↗
Want quality picks and reliable income at a discount? Check out these Dividend Aristocrats trading at 52-week lows. 
Via InvestorPlace
News headline image
AngioDynamics Resolves Decade-Long Patent Litigation With Becton, Dickinson In Settlement Agreement ↗
AngioDynamics resolves decade-long patent litigation with Becton, Dickinson in landmark settlement, streamlining legal expenses and marking a significant milestone for the company. 
Via Benzinga
Topics Intellectual Property
News headline image
Should You Buy Solventum (SOLV) Stock After the 3M Spinoff? ↗
Although 3M shareholders have reason to dump the Solventum spinoff, SOLV stock could be intriguing at the right price. 
Via InvestorPlace
News headline image
Jim Cramer Says Don't Sell This Beauty Brand, Believes KKR And Blackstone 'Can Make More Money' ↗
On CNBC’s "Mad Money Lightning Round," Jim Cramer sang the praises of Energy Transfer LP (NYSE: ET), which posted better-than-expected earnings 
Via Benzinga
News headline image
Becton, Dickinson And Co. Dividend Stock Analysis ↗
Becton, Dickinson, and Co. provides a wide range of medical devices and diagnostic products used in hospitals, doctors' offices, research labs, and other settings. 
Via Talk Markets
News headline image
FDA Probe On China-Made Syringes: Becton Dickinson Boosts US Syringe Output Following Concerns ↗
BD boosts U.S. production of medical syringes following FDA concerns over Chinese-made syringes. Learn how BD addresses patient care continuity amid ongoing quality probe. 
Via Benzinga
News headline image
10 Big-Name Stocks Near 52-Week Lows: Are They A Buy? ↗
Over the past twelve months a number of big named companies have been near or below their 52 week low price. Each week we’ll take a look at some of the biggest names currently close to their 52 week... 
Via Talk Markets
News headline image
7 Robotic Surgery Stocks to Buy for the Future of Healthcare ↗
Discover seven robotic surgery stocks primed for growth as the industry evolves. Unveil opportunities in a market set to double by 2033. 
Via InvestorPlace
News headline image
3 Dividend Kings of Healthcare Stocks to Buy Hand Over Fist in March ↗
These are some of the best-performing stocks in what's arguably society's most important industry. 
Via The Motley Fool
News headline image
3 Stocks to Buy at 52-Week Lows: March 4 Edition ↗
Sometimes a gem can get tossed in the trash, which is what you will find with these three stocks to buy at 52-week lows. 
Via InvestorPlace
News headline image
Get Paid While You Wait: 7 Dividend Aristocrats to Buy Now ↗
Worried about an upcoming market correction? These seven Dividend Aristocrats are a safe harbor which offer great income streams. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.